Glienty 2 mg Tablet (Glymeperide)
Glimepiride 2mg
Tablet · Prescription medication
Korea Sintex Pharmaceutical Co., Ltd.
MFDS item code 201906215 · Approved 2019.09.02
This product's status changed to Expired on 2024.09.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. Taking this medication along with dietary and exercise therapy can effectively manage blood sugar levels. It can be used alone, but if blood sugar control is insufficient, it can be combined with other hypoglycemic agents or insulin for treatment. Particularly, when monotherapy with sulfonylureas or metformin is ineffective, this medication is used in conjunction with metformin to improve blood sugar control, supporting effective management tailored to individual patients. This medication is used to enhance blood sugar control in patients with type 2 diabetes.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at 1 ~ 2-week intervals. The potency and duration of action of the previously administered drug should be considered. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Patients allergic to this medication, its ingredients, or sulfonylurea drugs should also avoid it. Patients with severe liver or kidney dysfunction are recommended to switch to insulin therapy instead of using this medication. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Insulin therapy is necessary for patients with severe infections, post-surgery, or substantial trauma, hence this medication should not be used. Patients who cannot properly absorb food due to diarrhea or vomiting may be at risk of hypoglycemia and should be cautious. This medication contains lactose, so patients with genetic lactose intolerance should not take it. During the initial week of treatment, there is a high risk of hypoglycemia, so blood sugar should be carefully monitored. Special caution is needed in the elderly, uncooperative patients, those with poor nutritional status or who skip meals, and when the balance between exercise and diet is not maintained. Patients who frequently consume alcohol or have compromised liver or kidney function are also at a higher risk of hypoglycemia. Additionally, patients with endocrine diseases such as thyroid, pituitary, or adrenal disorders, or those who overdose on this medication should be cautious. When used in combination with other medications, interactions may affect blood sugar control, so it should always be discussed with a physician. This medication contains Yellow No. 4 (Tartrazine), which may cause allergic reactions in susceptible patients. Due to the blood-sugar-lowering action of this medication, hypoglycemic symptoms may occur. Symptoms of hypoglycemia can include headaches, severe hunger, nausea, fatigue, anxiety, decreased concentration, confusion, blurred vision, dizziness, drowsiness, and loss of consciousness. In severe cases, it may lead to seizures or coma, so if hypoglycemic symptoms appear, immediate intake of sugar or consultation with medical personnel is necessary. Rarely, initial administration may cause blurred vision, digestive disorders, liver function abnormalities, blood disorders, or allergic reactions, so any unusual symptoms should be reported to a healthcare provider. When taking this medication, it is important to adhere to dietary and exercise regimens, and to take the medication regularly. Quickly consuming sugar during hypoglycemia can alleviate symptoms, so always carrying sugar is advisable. Patients and families should be thoroughly informed about hypoglycemic symptoms, treatments, and risk factors. If blood sugar control is insufficient or lifestyle changes occur, consultation with a physician for dose adjustment may be necessary. While taking other medications, interactions with this medication may occur, so patients must inform healthcare personnel of any concurrently used drugs. Care should be taken when using medications that affect enzymes that break down drugs in the liver or medications that raise or lower blood sugar levels. Alcohol consumption should be avoided as it can affect blood sugar control with this medication. Pregnant or breastfeeding women should not take this medication and, if necessary, switching to insulin therapy is safer. For children under 18 years of age, the safety and efficacy of this medication have not been established, so its use is not recommended. In elderly patients, who may have reduced kidney function, careful dosage adjustment is advised. In cases of overdose, severe hypoglycemia may occur, so immediate visit to a healthcare institution for appropriate treatment is necessary. In emergencies, glucose injections should be used to rapidly restore blood sugar, and subsequent monitoring for potential hypoglycemia recurrence should continue for at least 24 to 48 hours. This medication should be kept out of the reach of children and stored in the original container sealed properly.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, anemia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is advisable to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
Green rectangular tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 2mg
Tablet · Prescription medication
Korea Sintex Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.